Connect with us

Press Releases

MellingMedical and TearLab Agreement Aims to Enhance Early Detection of Dry Eye Disease in American Veterans

One-third of veterans currently diagnosed with this quality-of-life diminishing condition.




(PRESS RELEASE) ESCONDIDO, CA and ALEXANDRIA, VA — TearLab Corporation (privately held), a leader in Ocular Surface Diagnostics and MellingMedical, a CVE-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), announced an agreement that will empower physicians to more effectively diagnose dry eye disease (DED) among veterans.

DED is a very common condition that causes a variety of symptoms including burning eyes, light sensitivity, and fluctuating or blurred vision. Patients suffering from DED have a decreased quality of life and a reduced ability to carry out their activities of daily living.

“We are excited to bring osmolarity testing to America’s veterans and help support their patient care and therapy decisions,” said Chris Melling, founder and CEO of MellingMedical.

Established in more than 100 studies and publications and with over 20 million tests completed to date, the TearLab Osmolarity System uniquely aids physicians in the diagnosis of dry eye by providing precise, predictive, and objective results in 90 seconds. Leading ophthalmology groups have deemed this test essential in detecting significant ocular surface disease as part of the pre-operative workup.

“Osmolarity testing helps empower physicians with an objective and early detection of DED, and provides them with a faster feedback loop to evaluate the impact of therapeutic decisions over a period of weeks instead of months,2,3” said Adam Szaronos, Chief Commercial Officer of TearLab. “This partnership with MellingMedical now enables veterans and teaching hospitals across the US to access this technology for their patients.”

Contact for more information.




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular